CD4 and neoplasm: In this issue of the JCI, Taves, Otsuka, and colleagues show that murine tumor cell lines express the enzyme 11β-HSD1 and could reconvert inactive GCs to their active metabolites, which in turn promoted tumor growth by potentiating the immunosuppressive capacity of CD4+ Tregs (6).